Equity Overview
Price & Market Data
Price: $49.36
Daily Change: -$52.17 / 105.7%
Daily Range: $45.13 - $58.58
Market Cap: $1,957,297,408
Daily Volume: 15,475,704
Performance Metrics
1 Week: -47.64%
1 Month: -50.32%
3 Months: -38.36%
6 Months: 56.08%
1 Year: 5.13%
YTD: -41.34%
Company Details
Employees: 1000
Sector: Health technology
Industry: Medical specialties
Country:
Details
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.